{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:29:58Z","timestamp":1786984198622,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017317","name":"Catholic Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023320","name":"The Catholic University of Korea College of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ajo.2025.08.048","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T06:28:02Z","timestamp":1755930482000},"page":"472-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Subretinal Hyperreflective Material, Atrophy, and Intraretinal Fluid in Pachychoroid Neovasculopathy"],"prefix":"10.1016","volume":"280","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6736-5379","authenticated-orcid":false,"given":"Jiwon","family":"Baek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho","family":"Ra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chui Ming Gemmy","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7039-1762","authenticated-orcid":false,"given":"Won Ki","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2025.08.048_bib0001","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41433-024-03253-4","article-title":"Pachychoroid disease: review and update","volume":"39","author":"Cheung","year":"2024","journal-title":"Eye (Lond)"},{"issue":"9","key":"10.1016\/j.ajo.2025.08.048_bib0002","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.ophtha.2013.01.073","article-title":"Macular morphology and visual acuity in the comparison of age-related macular degeneration treatments trials","volume":"120","author":"Jaffe","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2025.08.048_bib0003","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ajo.2016.06.031","article-title":"Subretinal hyperreflective material imaged with optical coherence tomography angiography","volume":"169","author":"Dansingani","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2025.08.048_bib0004","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.oret.2021.02.012","article-title":"Longitudinal assessment of ellipsoid zone integrity, subretinal hyperreflective material, and subretinal pigment epithelium disease in neovascular age-related macular degeneration","volume":"5","author":"Ehlers","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"10.1016\/j.ajo.2025.08.048_bib0005","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/IAE.0000000000001748","article-title":"Prognostic value of subretinal hyperreflective material in neovascular age-related macular degeneration treated with bevacizumab","volume":"38","author":"Pokroy","year":"2018","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ajo.2025.08.048_bib0006","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/IAE.0000000000000166","article-title":"Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration","volume":"34","author":"Shah","year":"2014","journal-title":"Retina"},{"issue":"5","key":"10.1016\/j.ajo.2025.08.048_bib0007","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.oret.2017.08.019","article-title":"Tomographic biomarkers predicting progression to fibrosis in treated neovascular age-related macular degeneration: a multimodal imaging study","volume":"2","author":"Casalino","year":"2018","journal-title":"Ophthalmol Retina"},{"issue":"suppl 1","key":"10.1016\/j.ajo.2025.08.048_bib0008","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1097\/IAE.0b013e3182434da4","article-title":"Peripheral retinal detachments and retinal pigment epithelial atrophic tracts secondary to central serous pigment epitheliopathy. 1984","volume":"32","author":"Yannuzzi","year":"2012","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.ajo.2025.08.048_bib0009","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.oret.2017.08.016","article-title":"Pachychoroid geographic atrophy: clinical and genetic characteristics","volume":"2","author":"Takahashi","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ajo.2025.08.048_bib0010","article-title":"Foveal atrophy in patients with active central serous chorioretinopathy at first presentation: characteristics and treatment outcomes","author":"Son","year":"2024","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2025.08.048_bib0011","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1007\/s00417-019-04388-x","article-title":"Retinoschisis in eyes with pachychoroid and retinal pigment epithelial atrophy","volume":"257","author":"Baek","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.08.048_bib0012","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s10384-021-00815-x","article-title":"Characteristics and treatment responses of cystoid retina associated with central serous chorioretinopathy","volume":"65","author":"Fukuyama","year":"2021","journal-title":"Jpn J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.08.048_bib0013","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0002-9394(02)01438-1","article-title":"Retinal atrophy in idiopathic central serous chorioretinopathy","volume":"133","author":"Wang","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.08.048_bib0014","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/bjo.77.6.349","article-title":"Subretinal exudative deposits in central serous chorioretinopathy","volume":"77","author":"Ie","year":"1993","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.08.048_bib0015","article-title":"Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy","volume":"11","author":"Yoon","year":"2021","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.ajo.2025.08.048_bib0016","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ajo.2014.10.035","article-title":"Risk factors for geographic atrophy after intravitreal Ranibizumab injections for retinal angiomatous proliferation","volume":"159","author":"Cho","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.08.048_bib0017","article-title":"Geographic atrophy in Asia","author":"Cheung","year":"2025","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.08.048_bib0018","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ajo.2015.01.032","article-title":"Macular atrophy progression and 7-year vision outcomes in subjects from the ANCHOR, MARINA, and HORIZON studies: the SEVEN-UP study","volume":"159","author":"Bhisitkul","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.08.048_bib0019","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ophtha.2013.10.019","article-title":"Risk of scar in the comparison of age-related macular degeneration treatments trials","volume":"121","author":"Daniel","year":"2014","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2025.08.048_bib0020","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.3390\/jcm12093049","article-title":"Prognostic optical coherence tomography biomarkers in neovascular age-related macular degeneration","volume":"12","author":"Nawash","year":"2023","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.ajo.2025.08.048_bib0021","article-title":"Treatment and characteristics of pachychoroid neovasculopathy accompanying recalcitrant intraretinal cysts","volume":"16","author":"Choi","year":"2024","journal-title":"Cureus"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425004611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425004611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T04:14:46Z","timestamp":1779855286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425004611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":21,"alternative-id":["S0002939425004611"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.08.048","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subretinal Hyperreflective Material, Atrophy, and Intraretinal Fluid in Pachychoroid Neovasculopathy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.08.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}